{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T01:17:08Z","timestamp":1774055828926,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,2]]},"DOI":"10.7759\/cureus.53474","type":"journal-article","created":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T03:46:57Z","timestamp":1706932017000},"source":"Crossref","is-referenced-by-count":2,"title":["Enhancement of Ovarian Reserve and Oocyte Quality After Platelet-Rich Plasma Instillation in a Woman With Diminished Anti-M\u00fcllerian Hormone"],"prefix":"10.7759","author":[{"given":"Jarul","family":"Shrivastava","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akash","family":"More","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virul","family":"Shrivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Namrata","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepti","family":"Shrivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2015.06.015","article-title":"Assessing ovarian response: antral follicle count versus anti-M\u00fcllerian hormone","volume":"31","author":"Fleming R","year":"2015","unstructured":"Fleming R, Seifer DB, Frattarelli JL, Ruman J. Assessing ovarian response: antral follicle count versus anti-M\u00fcllerian hormone. Reprod Biomed Online. 2015, 31:486-96. 10.1016\/j.rbmo.2015.06.015","journal-title":"Reprod Biomed Online"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2013.07.1519","article-title":"AMH in women with diminished ovarian reserve: potential differences by FMR1 CGG repeat level","volume":"31","author":"Pastore LM","year":"2014","unstructured":"Pastore LM, McMurry TL, Williams CD, Baker VL, Young SL. AMH in women with diminished ovarian reserve: potential differences by FMR1 CGG repeat level. J Assist Reprod Genet. 2014, 31:1295-301. 10.1016\/j.fertnstert.2013.07.1519","journal-title":"J Assist Reprod Genet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/ar3914","article-title":"Platelet-rich plasma therapy - future or trend?","volume":"14","author":"Dhillon RS","year":"2012","unstructured":"Dhillon RS, Schwarz EM, Maloney MD. Platelet-rich plasma therapy - future or trend?. Arthritis Res Ther. 2012, 14:219. 10.1186\/ar3914","journal-title":"Arthritis Res Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-021-00826-w","article-title":"Evaluation of intra-ovarian platelet-rich plasma administration on oocytes-dependent variables in patients with poor ovarian response: a retrospective study according to the POSEIDON criteria","volume":"19","author":"Farimani M","year":"2021","unstructured":"Farimani M, Nazari A, Mohammadi S, Anvari Aliabad R. Evaluation of intra-ovarian platelet-rich plasma administration on oocytes-dependent variables in patients with poor ovarian response: a retrospective study according to the POSEIDON criteria. Reprod Biol Endocrinol. 2021, 19:137. 10.1186\/s12958-021-00826-w","journal-title":"Reprod Biol Endocrinol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5653\/cerm.2018.45.2.67","article-title":"Current clinical applications of platelet-rich plasma in various gynecological disorders: an appraisal of theory and practice","volume":"45","author":"Dawood AS","year":"2018","unstructured":"Dawood AS, Salem HA. Current clinical applications of platelet-rich plasma in various gynecological disorders: an appraisal of theory and practice. Clin Exp Reprod Med. 2018, 45:67-74. 10.5653\/cerm.2018.45.2.67","journal-title":"Clin Exp Reprod Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2018.1445219","article-title":"First data on in vitro fertilization and blastocyst formation after intraovarian injection of calcium gluconate-activated autologous platelet rich plasma","volume":"34","author":"Sills ES","year":"2018","unstructured":"Sills ES, Rickers NS, Li X, Palermo GD. First data on in vitro fertilization and blastocyst formation after intraovarian injection of calcium gluconate-activated autologous platelet rich plasma. Gynecol Endocrinol. 2018, 34:756-60. 10.1080\/09513590.2018.1445219","journal-title":"Gynecol Endocrinol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20190805","article-title":"Autologous activated platelet-rich plasma injection into adult human ovary tissue: molecular mechanism, analysis, and discussion of reproductive response","volume":"39","author":"Sills ES","year":"2019","unstructured":"Sills ES, Wood SH. Autologous activated platelet-rich plasma injection into adult human ovary tissue: molecular mechanism, analysis, and discussion of reproductive response. Biosci Rep. 2019, 39:10.1042\/BSR20190805","journal-title":"Biosci Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8010001","article-title":"Autologous platelet-rich plasma treatment enables pregnancy for a woman in premature menopause","volume":"8","author":"Sfakianoudis K","year":"2018","unstructured":"Sfakianoudis K, Simopoulou M, Nitsos N, et al.. Autologous platelet-rich plasma treatment enables pregnancy for a woman in premature menopause. J Clin Med. 2018, 8:1. 10.3390\/jcm8010001","journal-title":"J Clin Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2017.04.007","article-title":"Platelet-rich plasma promotes the development of isolated human primordial and primary follicles to the preantral stage","volume":"35","author":"Hosseini L","year":"2017","unstructured":"Hosseini L, Shirazi A, Naderi MM, et al.. Platelet-rich plasma promotes the development of isolated human primordial and primary follicles to the preantral stage. Reprod Biomed Online. 2017, 35:343-50. 10.1016\/j.rbmo.2017.04.007","journal-title":"Reprod Biomed Online"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.18632\/aging.103403","article-title":"Effects of intraovarian injection of autologous platelet rich plasma on ovarian reserve and IVF outcome parameters in women with primary ovarian insufficiency","volume":"12","author":"Cakiroglu Y","year":"2020","unstructured":"Cakiroglu Y, Saltik A, Yuceturk A, et al.. Effects of intraovarian injection of autologous platelet rich plasma on ovarian reserve and IVF outcome parameters in women with primary ovarian insufficiency. Aging (Albany NY). 2020, 12:10211-22. 10.18632\/aging.103403","journal-title":"Aging (Albany NY)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s43032-021-00483-9","article-title":"Effects of intraovarian injection of autologous platelet-rich plasma on ovarian rejuvenation in poor responders and women with primary ovarian insufficiency","volume":"28","author":"Aflatoonian A","year":"2021","unstructured":"Aflatoonian A, Lotfi M, Saeed L, Tabibnejad N. Effects of intraovarian injection of autologous platelet-rich plasma on ovarian rejuvenation in poor responders and women with primary ovarian insufficiency. Reprod Sci. 2021, 28:2050-9. 10.1007\/s43032-021-00483-9","journal-title":"Reprod Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s43032-020-00266-8","article-title":"Ovarian rejuvenation through platelet-rich autologous plasma (PRP)\u2014a chance to have a baby without donor eggs, improving the life quality of women suffering from early menopause without synthetic hormonal treatment","volume":"27","author":"Petryk N","year":"2020","unstructured":"Petryk N, Petryk M. Ovarian rejuvenation through platelet-rich autologous plasma (PRP)\u2014a chance to have a baby without donor eggs, improving the life quality of women suffering from early menopause without synthetic hormonal treatment. Reprod Sci. 2020, 27:1975-82. 10.1007\/s43032-020-00266-8","journal-title":"Reprod Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00050","article-title":"Live birth in woman with premature ovarian insufficiency receiving ovarian administration of platelet-rich plasma (PRP) in combination with gonadotropin: a case report","volume":"11","author":"Hsu CC","year":"2020","unstructured":"Hsu CC, Hsu L, Hsu I, Chiu YJ, Dorjee S. Live birth in woman with premature ovarian insufficiency receiving ovarian administration of platelet-rich plasma (PRP) in combination with gonadotropin: a case report. Front Endocrinol (Lausanne). 2020, 11:50. 10.3389\/fendo.2020.00050","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/13102818.2022.2090280","article-title":"Autologous ovarian platelet rich plasma treatment improves oocyte and embryo quality: a before-after prospective study","volume":"36","author":"Parvanov D","year":"2022","unstructured":"Parvanov D, Ganeva R, Vidolova N, et al.. Autologous ovarian platelet rich plasma treatment improves oocyte and embryo quality: a before-after prospective study. Biotechnol Biotechnol Equip. 2022, 36:425-32. 10.1080\/13102818.2022.2090280","journal-title":"Biotechnol Biotechnol Equip"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/226205-enhancement-of-ovarian-reserve-and-oocyte-quality-after-platelet-rich-plasma-instillation-in-a-woman-with-diminished-anti-mllerian-hormone","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:16:37Z","timestamp":1707509797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/226205-enhancement-of-ovarian-reserve-and-oocyte-quality-after-platelet-rich-plasma-instillation-in-a-woman-with-diminished-anti-mllerian-hormone"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,2]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.53474","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,2]]}}}